Bronchodilator Reversibility, Exercise Performance And ... - PubMed

Clipboard, Search History, and several other advanced features are temporarily unavailable. Skip to main page content

The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Search: Search Advanced Clipboard Save Email Send to

• Clipboard
• My Bibliography
• Collections
• Citation manager

Display options Display options Format Abstract PubMed PMID

Save citation to file

Format: Summary (text) PubMed PMID Abstract (text) CSV Create file Cancel

Email citation

Email address has not been verified. Go to My NCBI account settings to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email Cancel

Add to Collections

• Create a new collection
• Add to an existing collection

Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error Please try again Add Cancel

Add to My Bibliography

• My Bibliography

Unable to load your delegates due to an error Please try again Add Cancel

Your saved search

Name of saved search: Search terms: Test search terms Would you like email updates of new search results? Saved Search Alert Radio Buttons

• Yes
• No

Email: (change) Frequency: Monthly Weekly Daily Which day? The first Sunday The first Monday The first Tuesday The first Wednesday The first Thursday The first Friday The first Saturday The first day The first weekday Which day? Sunday Monday Tuesday Wednesday Thursday Friday Saturday Report format: Summary Summary (text) Abstract Abstract (text) PubMed Send at most: 1 item 5 items 10 items 20 items 50 items 100 items 200 items Send even when there aren't any new results Optional text in email: Save Cancel

Create a file for external citation management software

Create file Cancel

Your RSS Feed

Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link Copy

Actions

CiteCollectionsAdd to Collections

• Create a new collection
• Add to an existing collection

Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an errorPlease try again Add Cancel PermalinkPermalinkCopyDisplay options Display options Format AbstractPubMedPMID

Page navigation

• Title & authors
• Abstract
• Publication types
• MeSH terms
• Substances

Title & authors Abstract Publication types MeSH terms Substances CiteDisplay options Display options Format AbstractPubMedPMID

Abstract

Partial bronchodilator reversibility can be demonstrated in many patients with stable chronic obstructive pulmonary disease (COPD), but its relevance to exercise capacity and symptoms is uncertain. Previous data suggest that anticholinergic bronchodilators do not improve exercise tolerance in such patients. We studied 32 patients with stable COPD, mean age 65 yrs, in a double-blind, placebo-controlled, cross-over trial of the inhaled anticholinergic drug, oxitropium bromide. From the within and between day placebo spirometry, we derived the spontaneous variation in forced expiratory volume in one second (FEV1) and forced vital capacity (FVC) of this population (FEV1 140 ml; FVC 390 ml) and considered responses beyond this to be significant. Oxitropium bromide increased baseline FEV1 from 0.70 (0.28) l (mean (SD)) to 0.88 (0.36) l. The 6 min walking distance increased by 7% compared with placebo, whilst resting breathlessness scores fell from 2.0 to 1.23 at rest and 4.09 to 3.28 at the end of exercise after the active drug. Improvements in walking distances and symptoms were unrelated to changes in either FEV1 or FVC, indicating that routine reversibility testing is not a good predictor of symptomatic benefit in these patients.

PubMed Disclaimer

Publication types

• Clinical Trial Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Multicenter Study Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Randomized Controlled Trial Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search

MeSH terms

• Aged Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Bronchi / drug effects* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Bronchodilator Agents / therapeutic use* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Double-Blind Method Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Dyspnea / physiopathology Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Exercise / physiology Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Female Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Forced Expiratory Volume / drug effects Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Humans Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Lung Diseases, Obstructive / drug therapy* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Lung Diseases, Obstructive / physiopathology Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Male Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Parasympatholytics / therapeutic use* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Scopolamine Derivatives / therapeutic use* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Time Factors Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Vital Capacity / drug effects Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search

Substances

• Bronchodilator Agents Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Parasympatholytics Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Scopolamine Derivatives Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• oxitropium Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search

[x] Cite Copy Download .nbib .nbib Format: AMA APA MLA NLM Send To

• Clipboard
• Email
• Save
• My Bibliography
• Collections
• Citation Manager

[x]

NCBI Literature Resources

MeSH PMC Bookshelf Disclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.